Meeting NewsVideo

VIDEO: Aflibercept ‘greatly reduced’ rates of vision-threatening complications in diabetic retinopathy

CHICAGO — At the American Society of Retina Specialists meeting, W. Lloyd Clark, MD, discusses his presentation on the PANORAMA study for the treatment of diabetic retinopathy with Eylea (aflibercept, Regeneron) and results at 1 year.

CHICAGO — At the American Society of Retina Specialists meeting, W. Lloyd Clark, MD, discusses his presentation on the PANORAMA study for the treatment of diabetic retinopathy with Eylea (aflibercept, Regeneron) and results at 1 year.

    See more from ASRS 2019